The Patient-Centered Outcomes Research Institute has launched its Cycle 3 2025 funding initiative aimed at supporting high-impact, patient-centered comparative clinical effectiveness research focused on rare diseases. This opportunity invites studies that compare different approaches to prevention, diagnosis, treatment, or care delivery in ways that meaningfully improve outcomes for individuals and families facing these challenging conditions.
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: